Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04735796
Title Study of LM-102 in Subjects in Advanced Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors LaNova Medicines Limited
Indications

colorectal carcinoma

gastric adenocarcinoma

ovarian carcinoma

gastroesophageal junction adenocarcinoma

biliary tract cancer

Advanced Solid Tumor

pancreatic carcinoma

Therapies

LM-102

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.